Skip to main content
. 2012 Dec 4;76(3):432–444. doi: 10.1111/bcp.12056

Figure 3.

Figure 3

Formation rates of (A) D3OG and (B) D2OG after incubation of dapagliflozin with human kidney, liver or intestine microsomes at a protein concentration of 0.25 mg ml−1 in the presence of uridine 5′-diphosphoglucuronic acid. D2OG, dapagliflozin 2-O-glucuronide; D3OG, dapagliflozin 3-O-glucuronide; T2DM, type 2 diabetes mellitus. Inline graphic, human liver microsomes; Inline graphic, human kidney microsomes; Inline graphic, human intestine microsomes